TICAROS

TiCARos

Enhanced T Cell Therapy:

Next Generation Gene-modification

We develop the next generation immunotherapeutics for complete cure of intractable cancers

TiCARos

Enhanced T Cell Therapy:

Next Generation Gene-modification

We develop the next generation immunotherapeutics for complete cure of intractable cancers

TiCARos

Enhanced T Cell Therapy:

Next Generation Gene-modification

We develop the next generation immunotherapeutics for complete cure of intractable cancers

Scroll Down

TiCARos Story

TiCARos Co.Ltd is a biotech company which develops the next generation immunotherapeutics for cancers

Science & Technology

CAR-T
THERAPY

Chimeric Antigen Receptor T cell Therapy : A genetically engineered T cell therapy, in which T cells isolated from the cancer patient are converted into tumor-killing T cells by introducing tumor-targeting antibody-based receptor (chimeric antigen receptor) and are infused back to the patient

MORE VIEW

Science & Technology

CLIP CAR
PLATFORM

CLIP-CAR (Clamping-based Immunological Synapse Potentiating CAR) technology improved CAR-T cell efficacy by stabilizing immune synapse between cancer cells and surface of CAR-T cells through a new CAR backbone structure

MORE VIEW

Science & Technology

CONVERTER
CAR PLATFORM

CTLA-4, an immune checkpoint receptor, is selectively inhibited in tumor-specific T cells to potentiate its anti-tumor activity without autoimmune adverse side effects

MORE VIEW

CAR-T THERAPY CLIP CAR PLATFORM CONVERTER CAR PLATFORM

PIPELINE

IMMNUNO-ONCOLOGY

TiCARos proposes a new treatment option using cutting-edge technology in immunology and antibody-engineering
We develop best-in class, first-in class therapies based on Converter CAR platform for better T cell
activity and on CLIP CAR platform for more stable immune synapse of CAR-T cells

MORE VIEW

TiCARos